The thymic suppre-sor cell. II. Metabolic requirements of suppressor activity.
D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D002417:Cattle / Q000276:immunology; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D007114:Immunization; D007117:Immunization, Secondary; D007165:Immunosuppression Therapy; D037102:Lectins; D007930:Leucine / Q000378:metabolism; D008213:Lymphocyte Activation; D017710:Lymphocyte Transfusion; D008297:Male; D008937:Mitomycins / Q000494:pharmacology; D014176:Protein Biosynthesis; D051381:Rats; D011917:Rats, Inbred Lew; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D014185:Transplantation, Isogeneic; D014316:Tritium; D005719:gamma-Globulins
D037102:Lectins; D008937:Mitomycins; D005719:gamma-Globulins; D014316:Tritium; D003609:Dactinomycin; D000968:Antimycin A; D003513:Cycloheximide; D007930:Leucine; D013936:Thymidine